This study of Adolescent Boys and Young Men highlights the importance of engaging adolescent boys and young men in sexual and reproductive health and rights (srhr) and gender equality.  This paper establishes a conceptual framework for engaging adolescent boys and young men. It reviews current resea...rch on boys’ and young men’s specific risks and realities in relation to their general health status, violence, sexuality and sexual and reproductive health, media violence, sexual exploitation, and other vulnerabilities. 
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                PlosOne Published: July 14, 2021
https://doi.org/10.1371/journal.pone.0254339
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Diagnóstico y tratamiento de sífilis recomendaciones para los equipos de salud.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Guidelines for the Management and Therapy of Urinary Tract Infection and Male Genitalia in Indonesia 
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The intended purpose of this compendium is to provide program managers, organizations, and policy makers with a menu of indicators to better “know their HIV epidemic/know their response” from a gender perspective. The indicators in the compendium are all either part of existing indicators used i...n studies or by countries or have been adapted from existing indicators to address the intersection of gender and HIV. The indicators can be measured through existing data collection and information systems (e.g. routine program monitoring, surveys) in most country contexts, though some may require special studies or research.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Lancet Infect Dis 2022;
22: 222–4
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of
recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac...cination may lead to lower adherence to the existing
preventive measures. The advice from the World Health Organization (WHO) was to continue these public health and
social measures after being vaccinated.1  However, evidence from other epidemics suggests that there is lower adherence to
preventive measures when some level of protection exists (for example, individuals who use human immunodeficiency virus
pre-exposure prophylaxis
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Se sabe que las mujeres embarazadas experimentan cambios inmunológicos y fisiológicos que pueden  hacerlas  más  susceptibles  a  las  infecciones  respiratorias  virales,  incluido  COVID-19. Varios   estudios   revelaron   que   las   mujeres   embarazadas   con   diferentes   enfermedades resp...iratorias   virales   tenían   un   alto   riesgo   de   desarrollar   complicaciones   obstétricas   y resultados  adversos  perinatales  en  comparación  con  las  mujeres  no  grávidas,  debido  a  los cambios  en  las  respuestas  inmunes.  También  sabemos  que  las  mujeres  embarazadas  pueden estar  en  riesgo  de  enfermedad  grave,  morbilidad  o  mortalidad  en  comparación  con  la población  general,  tal  y  como  se  observa  en  los  casos  de  otras  infecciones  por  coronavirus 
5relacionadas  [incluido  el  coronavirus  del  síndrome  respiratorio  agudo  severo  (SARS-CoV)  y  el coronavirus  del  síndrome  respiratorio  del  Medio  Oriente  (MERS-CoV)]  y  otras  infecciones respiratorias virales, como la gripe, durante el embarazo.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19.
The specific objectives of the analysis were to: 
    describe the clinical char...acteristics and outcomes of PLHIV hospitalized for COVID-19
    assess whether PLHIV hospitalized with COVID-19 were at increased risk of presenting with severe or critical illness at admission and were at increased risk of in-hospital death compared to individuals not infected with HIV
    assess risk factors associated with severe or critical illness at hospital admission and of in-hospital death among PLHIV hospitalized for COVID-19.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...LASS report.
The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017.
The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy.
                                                                    more